Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in COVID-19 Patients without Pneumonia
2020-005214-18Phase 3Withdrawn
- Sponsor
- Vilnius University Hospital Santaros Klinikos
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Vilnius University Hospital Santaros Klinikos. Primary endpoint: Time to improvement of clinical and virologic parameters. Planned start Nov 2020; status: withdrawn.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-005214-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005214-18.